The impact of switching to Clozapine on concomitant psychotropic and non-psychotropic polypharmacy in schizophrenia

被引：0
|
作者：
Deakin, IH [1 ]
Miller, J [1 ]
Wilson, J [1 ]
Brown, K [1 ]
Strickland, P [1 ]
Haddad, P [1 ]
Dursun, SM [1 ]
机构：
[1] Manchester MHSS NHS Trust, Neurosci & Psychiat Unit, Salford, Lancs, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2003年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [41] Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
    Borrelli, Francesca
    Fasolino, Ines
    Romano, Barbara
    Capasso, Raffaele
    Maiello, Francesco
    Coppola, Diana
    Orlando, Pierangelo
    Battista, Giovanni
    Pagano, Ester
    Di Marzo, Vincenzo
    Izzo, Angelo A.
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (09) : 1306 - 1316
  • [42] Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review
    Alfei, Silvana
    Schito, Gian Carlo
    Schito, Anna Maria
    PHARMACEUTICS, 2023, 15 (07)
  • [43] Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol
    Pagano, Ester
    Montanaro, Vittorino
    di Girolamo, Antonio
    Pistone, Antonio
    Altieri, Vincenzo
    Zjawiony, Jordan K.
    Izzo, Angelo A.
    Capasso, Raffaele
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (06) : 1009 - 1012
  • [44] Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
    Espejo-Porras, Francisco
    Fernandez-Ruiz, Javier
    Pertwee, Roger G.
    Mechoulam, Raphael
    Garcia, Concepcion
    NEUROPHARMACOLOGY, 2013, 75 : 155 - 163
  • [45] Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
    Mammana, Santa
    Cavalli, Eugenio
    Gugliandolo, Agnese
    Silvestro, Serena
    Pollastro, Federica
    Bramanti, Placido
    Mazzon, Emanuela
    MEDICINA-LITHUANIA, 2019, 55 (11):
  • [46] Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol
    Ghovanloo, Mohammad-Reza
    Dib-Hajj, Sulayman D.
    Goodchild, Samuel J.
    Ruben, Peter C.
    Waxman, Stephen G.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [47] Regulation of GABA(A) Receptor Activity by Non-Psychotropic Drugs Suggest Treatment Options for Primary Hypersomnia
    Nash, Abigail I.
    Carlson, Joseph
    Freeman, Amanda A. H.
    Jenkins, Andrew
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 267S - 267S
  • [48] CLOZAPINE TREATMENT IN DENMARK - CONCOMITANT PSYCHOTROPIC MEDICATION AND HEMATOLOGIC MONITORING IN A SYSTEM WITH LIBERAL USAGE PRACTICES
    PEACOCK, L
    GERLACH, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1994, 55 (02) : 44 - 49
  • [49] Assessment of the Impact of Medical Fee Schedule Revision on Polypharmacy of Psychotropic Agents in Japan
    Nishikino, Rie
    Ito, Chie
    Tsuchiya, Shiori
    Onishi, Yoshie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 666 - 666
  • [50] INAPPROPRIATE USE OF NON-PSYCHOTROPIC MEDICATIONS AMONG NURSING-HOME RESIDENTS IN 2 STATES
    WILLIAMS, BC
    CLINICAL RESEARCH, 1993, 41 (02): : A531 - A531
12345